Matsuki Y, Suzuki K, Kawakami M, Ishizuka T, Kawaguchi Y, Hidaka T, Nakamura H
National Defense Medical College, Saitama, Japan.
J Clin Apher. 1996;11(1):30-5. doi: 10.1002/(SICI)1098-1101(1996)11:1<30::AID-JCA7>3.0.CO;2-C.
The purpose of this study is to determine whether immunoadsorption treatment using a dextran sulfate (DS) column can remove high-avidity anti-double-stranded DNA (anti-dsDNA) antibody from the blood of patients with systemic lupus erythematosus (SLE). Before and after each immunoadsorption therapy routine, titers of the high-avidity anti-dsDNA antibody of 11 SLE patients were measured by using a newly developed assay kit to exclusively detect high avidity anti-DNA antibody. Patients with active SLE showed significantly higher titers of high-avidity antibody than did those with inactive SLE, and their titers were significantly reduced by immunoadsorption procedures. Removal of high-avidity antibodies in vitro was also confirmed by mixing patients' sera and DS gel. Immunoadsorption therapy using DS columns is effective in the removal of high-avidity anti-dsDNA antibodies that are closely associated with pathogenicity in SLE.